Xu Mengqiao, Yang Qianhao, Sun Xiaodong, Wang Yue
Shanghai General Hospital, Shanghai, China.
National Clinical Research Center for Eye Diseases, Shanghai, China.
Front Bioeng Biotechnol. 2020 Nov 11;8:586130. doi: 10.3389/fbioe.2020.586130. eCollection 2020.
Exosomes have a rapid development of bio-nanoparticles for drug delivery and confluent advances in next-generation diagnostics, monitoring the progression of several diseases, and accurate guidance for therapy. Based on their prominent stability, cargo-carriage properties, stable circulating capability, and favorable safety profile, exosomes have great potential to regulate cellular communication by carrying variable cargoes into specific site. However, the specific loading strategies and modification methods for engineered exosomes to enhance the targeting ability are unclear. The clinical application of exosomes is still limited. In this review, we discuss both original and modified exosomes for loading specific therapeutic molecules (proteins, nucleic acids, and small molecules) and the design strategies used to target specific cells. This review can be used as a reference for further loading and modification strategies as well as for the therapeutic applications of exosomes.
外泌体作为用于药物递送的生物纳米颗粒发展迅速,在下一代诊断、监测多种疾病进展以及治疗的精准指导方面取得了显著进展。基于其突出的稳定性、载物特性、稳定的循环能力和良好的安全性,外泌体具有通过携带可变货物至特定部位来调节细胞通讯的巨大潜力。然而,用于增强工程化外泌体靶向能力的具体装载策略和修饰方法尚不清楚。外泌体的临床应用仍然有限。在本综述中,我们讨论了用于装载特定治疗分子(蛋白质、核酸和小分子)的原始外泌体和修饰外泌体,以及用于靶向特定细胞的设计策略。本综述可为外泌体进一步的装载和修饰策略以及治疗应用提供参考。